Robert Schrepfer's Insider Trades & SAST Disclosures
Robert Schrepfer's most recent trade in ANI Pharmaceuticals Inc was a trade of 5,566 Common Stock done at an average price of $32.7 . Disclosure was reported to the exchange on March 29, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Robert Schrepfer.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ANI Pharmaceuticals Inc | Robert Schrepfer | SVP - NEW BUS DEV & SPEC SALES | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.68 per share. | 29 Mar 2021 | 5,566 | 87,477 (0%) | 0% | 32.7 | 181,897 | Common Stock |
| ANI Pharmaceuticals Inc | Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2020 | 39,767 | 93,043 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.22 per share. | 06 Apr 2020 | 666 | 53,672 (0%) | 0% | 43.2 | 28,785 | Common Stock |
| ANI Pharmaceuticals Inc | Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.93 per share. | 06 Apr 2020 | 396 | 53,276 (0%) | 0% | 43.9 | 17,396 | Common Stock |
| ANI Pharmaceuticals Inc | Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.76 per share. | 28 Mar 2020 | 1,037 | 54,890 (0%) | 0% | 37.8 | 39,157 | Common Stock |
| ANI Pharmaceuticals Inc | Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.74 per share. | 28 Mar 2020 | 552 | 54,338 (0%) | 0% | 40.7 | 22,488 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges